Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Accounts Payables (2016 - 2019)

Historic Accounts Payables for Soleno Therapeutics (SLNO) over the last 7 years, with Q3 2019 value amounting to $1.7 million.

  • Soleno Therapeutics' Accounts Payables rose 3935.74% to $1.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $1.7 million, marking a year-over-year increase of 3935.74%. This contributed to the annual value of $934000.0 for FY2018, which is 4755.13% up from last year.
  • As of Q3 2019, Soleno Therapeutics' Accounts Payables stood at $1.7 million, which was up 3935.74% from $1.7 million recorded in Q2 2019.
  • Soleno Therapeutics' Accounts Payables' 5-year high stood at $1.7 million during Q2 2019, with a 5-year trough of $410512.0 in Q4 2016.
  • Over the past 5 years, Soleno Therapeutics' median Accounts Payables value was $957000.0 (recorded in 2016), while the average stood at $1.0 million.
  • Over the last 5 years, Soleno Therapeutics' Accounts Payables had its largest YoY gain of 10322.06% in 2016, and its largest YoY loss of 4093.83% in 2016.
  • Quarter analysis of 5 years shows Soleno Therapeutics' Accounts Payables stood at $695056.0 in 2015, then crashed by 40.94% to $410512.0 in 2016, then soared by 54.2% to $633000.0 in 2017, then skyrocketed by 47.55% to $934000.0 in 2018, then surged by 85.76% to $1.7 million in 2019.
  • Its last three reported values are $1.7 million in Q3 2019, $1.7 million for Q2 2019, and $1.3 million during Q1 2019.